Rein Therapeutics Inc (RNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,182 | 11,297 | 10,660 | 7,741 | 12,005 |
| Marketable Securities | 21,365 | 1,998 | 10,060 | 20,229 | 23,811 |
| TOTAL | $32,559 | $14,389 | $21,775 | $30,053 | $37,206 |
| Non-Current Assets | |||||
| PPE Net | 379 | 398 | 7,290 | 6,832 | 4,123 |
| Other Non-Current Assets | 7,255 | 7,612 | 1,247 | 1,248 | 1,248 |
| TOTAL | $7,634 | $8,010 | $8,537 | $8,080 | $5,371 |
| Total Assets | $40,193 | $22,399 | $30,312 | $38,133 | $42,577 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,719 | 858 | 1,731 | 2,994 | 1,583 |
| Accrued Expenses | 3,262 | 3,378 | 3,639 | 4,111 | 4,781 |
| TOTAL | $5,387 | $4,623 | $5,370 | $7,105 | $6,364 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 5,342 | 4,997 | 3,345 |
| Other Non-Current Liabilities | 4,822 | 4,929 | 0 | 0 | 0 |
| TOTAL | $4,822 | $4,929 | $5,342 | $4,997 | $3,345 |
| Total Liabilities | $10,209 | $9,552 | $10,712 | $12,102 | $9,709 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,391 | 1,336 | 744 | 737 | 737 |
| Common Shares | 28 | 15 | 15 | 15 | 15 |
| Retained earnings | -183,151 | -175,979 | -168,493 | -161,459 | -154,025 |
| Other shareholders' equity | 24 | 0 | -5 | -3 | -12 |
| TOTAL | $29,984 | $12,847 | $19,600 | $26,031 | $32,868 |
| Total Liabilities And Equity | $40,193 | $22,399 | $30,312 | $38,133 | $42,577 |